These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9625586)
21. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310 [TBL] [Abstract][Full Text] [Related]
22. The development of central venous thrombosis in hemodialyzed patients is associated with catheter tip depth and localization. Premuzic V; Perkov D; Smiljanic R Hemodial Int; 2018 Oct; 22(4):454-462. PubMed ID: 29722112 [TBL] [Abstract][Full Text] [Related]
23. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075 [TBL] [Abstract][Full Text] [Related]
24. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550 [TBL] [Abstract][Full Text] [Related]
25. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401 [TBL] [Abstract][Full Text] [Related]
26. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Lee DH; Warkentin TE; Denomme GA; Lagrotteria DD; Kelton JG Thromb Haemost; 1998 Jan; 79(1):50-3. PubMed ID: 9459322 [TBL] [Abstract][Full Text] [Related]
27. Catheter-associated recurrent intracardiac thrombosis and factor V Leiden mutation in a child with non-Hodgkin's lymphoma. Corapçioğlu F; Uysal KM; Silistreli E; Unal N; Oren H; Açikel U Turk J Pediatr; 2005; 47(3):279-82. PubMed ID: 16250317 [TBL] [Abstract][Full Text] [Related]
28. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457 [TBL] [Abstract][Full Text] [Related]
29. Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Arsov T; Miladinova D; Spiroski M Croat Med J; 2006 Jun; 47(3):433-9. PubMed ID: 16758522 [TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden. Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453 [TBL] [Abstract][Full Text] [Related]
31. Activated protein C resistance--a major risk factor for thrombosis. Rosén SB; Sturk A Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726 [TBL] [Abstract][Full Text] [Related]
32. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis. Eckman MH; Singh SK; Erban JK; Kao G Med Decis Making; 2002; 22(2):108-24. PubMed ID: 11958494 [TBL] [Abstract][Full Text] [Related]
33. The prevalence of factor V Leiden mutation in patients with leg ulcers and venous insufficiency. Maessen-Visch MB; Hamulyak K; Tazelaar DJ; Crombag NH; Neumann HA Arch Dermatol; 1999 Jan; 135(1):41-4. PubMed ID: 9923779 [TBL] [Abstract][Full Text] [Related]
34. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis. Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165 [TBL] [Abstract][Full Text] [Related]
35. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. Grossman D; Heald PW; Wang C; Rinder HM J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):409-13. PubMed ID: 9308555 [TBL] [Abstract][Full Text] [Related]
37. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Irish AB; Green FR; Gray DW; Morris PJ Transplantation; 1997 Aug; 64(4):604-7. PubMed ID: 9293873 [TBL] [Abstract][Full Text] [Related]
38. Factor V Leiden mutation in patients with Behçet's disease. Oner AF; Gürgey A; Gürler A; Mesci L J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770 [TBL] [Abstract][Full Text] [Related]
39. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [TBL] [Abstract][Full Text] [Related]
40. Factor V Leiden mutation and type 1 diabetes mellitus. Demirer AN; Alikasifoglu M; Tuncbilek E; Karakus S; Erbas T Blood Coagul Fibrinolysis; 2008 Jan; 19(1):70-4. PubMed ID: 18180619 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]